Central Serous Chorioretinopathy (CSC) Completed Phase Trials for Bevacizumab (DB00112)

Also known as: Central Serous Chorioretinopathy / Central Serous Retinopathy (CSR) / Central Serous Retinopathy / Serous macular detachment

IndicationStatusPhase
DBCOND0050251 (Central Serous Chorioretinopathy (CSC))CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00802906Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)Treatment